8th May 2020
Platform allows individuals to report COVID-19 symptoms
The BuddyCare virtual care platform helps track COVID-19 symptoms and facilitate secure communications between individuals and healthcare professionals.
Buddy Healthcare Ltd Oy is offering the platform to hospitals and healthcare centres that are currently monitoring patients with suspected COVID-19.
How does the platform work?
- Hospitals assign citizens with mild symptoms or diagnosed infections to the COVID-19 mobile app, they can also register themselves
- Patients report their daily symptoms through the mobile app
- The hospital is notified when specific thresholds are met and can then directly request the individual to make an appointment.
Features of the mobile app designed for patients:
- Information and instructions about COVID-19 published by healthcare authorities and health agencies
- A daily symptom checker – this can be configured based on specific hospitals instructions. It can monitor signs such as fever, coughing, sore throat and breathing problems
- Secure communication channel between the individual and hospital.
Features of the monitoring dashboard designed for healthcare professionals:
- Identifies patients who require further attention
- Care personnel can monitor, periodically, the symptoms and well-being of at-risk individuals
- Alerts if a patient or individual has specific symptoms or exceeds thresholds
- Secure messaging allows patient’s risk-assessment based communication through which care personnel can contact those at risk or provide guidelines for home quarantine, self-isolation etc.
The platform is currently used by 18 hospital in 40 clinics in three different countries (Finland, Germany and the USA).
Healthcare authorities can also see pseudonymised statistics based on the data collected from patients.
Please contact Buddy Healthcare Ltd Oy for pricing information.
ASK: Research contributors needed for CON-VICE study
University of Luxembourg needs European researchers to get in touch
OFFER: Funding available for COVID-19 research
Fondation Air Liquide are looking to fund European projects
ASK: Supporting the immunocompromised
Partners sought to advance neutralising antibody